Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 26;2(4):100157.
doi: 10.1016/j.jacig.2023.100157. eCollection 2023 Nov.

Effect of the COVID-19 pandemic on asthma exacerbations in New Zealand: An interrupted time series analysis

Affiliations

Effect of the COVID-19 pandemic on asthma exacerbations in New Zealand: An interrupted time series analysis

Amy Hai Yan Chan et al. J Allergy Clin Immunol Glob. .

Abstract

Background: New Zealand (NZ) implemented some of the strictest restrictions during the novel coronavirus pandemic (coronavirus disease 2019 [COVID-19]), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). How this impacted asthma exacerbation rates in NZ is unknown.

Objective: We sought to explore the effects of the COVID-19 restrictions on asthma exacerbations in NZ during 2020.

Methods: We used a population-based, interrupted time series to examine the impact of the first COVID-19 lockdown in NZ on asthma exacerbation rate. The primary outcome measure was change in the monthly exacerbation rate, defined as hospitalization and/or course of corticosteroids, before and after the first lockdown. In a secondary analysis, we quantified the number of patients with asthma, the actual asthma exacerbation rate from March to December 2019 versus March to December 2020, and the number of asthma hospitalizations.

Results: There was a significant drop in the exacerbation rate immediately after lockdown (-3.02; P < .0001) followed by a significant and sustained increasing trend; the rate postlockdown increased relative to that prelockdown (0.27; P < .0001). Similar patterns were observed in all sociodemographic groups. In our secondary analysis, we identified 507,622 people with asthma; this reduced to 458,023 in 2020 postlockdown. The overall asthma exacerbation rate was 33.3% less in 2020 than in 2019 (reduction from 48.6/1000 patients to 32.4/1000 patients). The rate of asthma hospitalizations decreased from 9.5 per 1000 patients in 2019 to 6.2 per 1000 patients in 2020; this decrease was observed across all demographic groups.

Conclusions: The first COVID-19 lockdown in 2020 in NZ significantly reduced asthma exacerbation rates across all sociodemographic groups. Whether these reductions are sustained requires further investigation.

Keywords: Asthma; COVID-19; exacerbations; hospitalizations; interrupted time series; pandemic; public health.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Asthma exacerbation rate time series analysis by month (2015-2020).
Fig 2
Fig 2
Asthma exacerbation rate by month and year (2015-2020).

Similar articles

Cited by

References

    1. Chan D.Z., Stewart R.A., Kerr A.J., Dicker B., Kyle C.V., Adamson P.D., et al. The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55) Lancet Regional Health-Western Pacific. 2020;5 - PMC - PubMed
    1. Clift A.K., Coupland C.A., Keogh R.H., Diaz-Ordaz K., Williamson E., Harrison E.M., et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ. 2020;371:m3731. - PMC - PubMed
    1. Garg S., Kim L., Whitaker M., O’Halloran A., Cummings C., Holstein R., et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, March 1–30, 2020. Morb Mortal Wkly Rep. 2020;69:458. - PMC - PubMed
    1. Jackson T., Mcclatchey K., Chan A., Morgan N., Pinnock H. Exploring the psychological impact of the COVID-19 pandemic on adults with asthma: a qualitative study. Eur Respir J. 2021;58:PA3563.
    1. McClatchey K., Jackson T., Delaney B., Morgan N., Pinnock H., Chan A.H.Y. COVID-19 information for people living with asthma: a rapid review of publicly available information. J Allergy Clin Immunol Pract. 2021;9:2070–2072. - PMC - PubMed

LinkOut - more resources